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Dysregulation of placental ABc 
transporters in a murine model of 
malaria-induced preterm labor
K. n. fontes1, M. W. Reginatto1, n. L. Silva1, c. B. V. Andrade1, f. f. Bloise  1, 
V. R. S. Monteiro1, J. L. Silva-filho2,9, G. e. imperio1,4, p. M. pimentel-coelho3, 
A. A. S. pinheiro2, S. G. Matthews4,5,6,7, e. Bloise8 & t. M. ortiga-carvalho  1
Malaria in pregnancy (Mip) is characterized by placental accumulation of Plasmodium-infected 
erythrocytes, intrauterine growth restriction (iUGR) and preterm delivery (ptD). placental Atp-binding 
cassette (ABC) transporters mediate the efflux of nutrients, cytokines and xenobiotics. The expression 
and activity of these transporters are highly responsive to infection. We hypothesized that Mip would 
perturb the expression of placental ABC transporters, promoting PTD. Peripheral blood, spleens, livers 
and placentas of pregnant mice, infected with Plasmodium berghei ANKA on gestational day (GD) 13.5, 
were collected and analyzed on GD18.5. The primary consequences of human MiP, including IUGR, 
PTD (20%) and placental inflammation, were recapitulated in our mouse model. Electron microscopy 
revealed attenuated presence of labyrinthine microvilli and dilated spongiotrophoblasts -granular 
endoplasmic reticulum cisternae. Additionally, a decrease in placental Abca1 (ABCA1), Abcb1b 
(p-glycoprotein), Abcb9 and Abcg2 (BCRP) expression was observed in MiP mice. In conclusion, MiP 
associated with PTD impairs placental ABC transporters’ expression, potentially modulating placental 
nutrient, environmental toxin and xenobiotic biodistribution within the fetal compartment, and may, 
at some degree, be involved with pregnancy outcome in Mip.
Preterm delivery (PTD) affects 8 to 12% of all pregnancies worldwide, with this number raising up to, approxi-
mately, 19% in some low and middle income countries1,2. The most common risk factors for spontaneous PTD 
include multiple gestations, use of toxic substances and intrauterine infection. The latter, accounts for approxi-
mately 40% of all cases of PTD globally3,4.
Intrauterine infection, caused by various infective agents (bacteria, viruses and protozoa), promotes inflam-
mation of the maternal-fetal unit, which occurs through the recognition of microbial antigens by the pattern 
recognition receptors (PRRs), and subsequent release of pro-inflammatory mediators capable of inducing labor5. 
Among these, an important infective disease is Malaria, a life-threatening disease that in 2016 affected 216 million 
people and caused approximately, 445.000 deaths globally6.
Malaria in Pregnancy (MiP) is highly associated with an increased risk of intrauterine growth restriction 
(IUGR), PTD, low birth weight, infant death and adverse postnatal cognitive and neurosensory development7. 
In fact, it is estimated that 125 million pregnant women reside in areas at risk of contracting MiP8. The average 
maternal mortality rate induced by MiP (which can be associated with severe anemia, hypoglycemia, acute res-
piratory distress syndrome, renal failure and cerebral malaria) is 39%. Importantly, up to 70% of IUGR and 36% 
of preterm delivery cases in malaria-endemic areas are related to Plasmodium sp. infection8.
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In humans, the pathogenesis of placental malaria includes accumulation of Plasmodium falciparum–infected 
erythrocytes into the intervillous space of the placenta. This culminates in the infiltration of placental immune 
cells, deposition of malarial pigment (hemozoin) in the placenta, thickening of the placental basement membrane, 
perivillous fibrinoid deposits and abnormal syncytial knotting. Interestingly, placental infection with Plasmodium 
vivax was shown to be associated with a much milder phenotype7,9. Furthermore, the pro-inflammatory placental 
microenvironment elicited by malaria sequestration is capable of compromising active transporter systems. As 
such, impaired expression and activity of amino acid transporters have been reported in human and experimental 
placental malaria and were correlated with increased rates of IUGR and low birth weight, which are both consid-
ered to be important consequences of MiP10,11.
Previous work also showed that BALB/c mice infection with Plasmodium berghei ANKA (from gestational day 
(GD) 13.5–19.5) was capable of impairing the placental expression of other active transporters belonging to the 
ATP-binding cassette (ABC) transporter family12. However, the pattern of placental ABC transporter expression, 
in a mouse model where PTD and low birth weight are simultaneously recapitulated, have not been investigated.
Functionally, ABC transporters are responsible for the movement of numerous physiological and pharmaco-
logical substrates across developing biological barriers (i.e. the placenta and fetal blood brain barrier). Among 
the ABC transporters, the best described are the ABC lipid transporter, ABCA1, and the ABC drug transporters, 
P‐glycoprotein (P‐gp, encoded by ABCB1 in humans and Abcb1a/Abcb1b in rodents), breast cancer resistance 
protein (BCRP, ABCG2) and the multidrug resistance‐associated proteins (MRPs‐2 and 5, ABCC2 and ABCC5). 
Physiological substrates of ABC transporters include: cholesterol, folic acid, steroid hormones and inflammatory 
mediators; whereas bisphenol A, many herbicides and pesticides, antibiotics, antiretrovirals and antidepressants 
represent nonphysiological substrates13,14. Thus, it is likely that altered placental ABC transporter expression 
caused by MiP could disturb the fetal biodisposition of these substrates with potentially significant effects on clin-
ical outcomes. Previous studies from our group have demonstrated that chorioamnionitis, as well as bacterial and 
viral challenges, alter the expression and activity of P-gp and BCRP in the human placenta, resulting in fetuses 
being exposed to unbalanced levels of nutrients, xenobiotics and environmental toxins present in the maternal 
circulation15–18.
Given the importance of ABC transporters in fetal nutrition and protection, and due to the fact that experi-
mental malaria alters the placental expression of key ABC transporters, we hypothesized that the dysregulation of 
ABC transporters is, at least partially, involved in the pathogenesis of MiP-induced PTD and associated low birth 
weight. In the present study, therefore, using an experimental cerebral malaria strategy19 induced by Plasmodium 
berghei ANKA infection in C57BL/6 mice, a new murine model of MiP-induced PTD was developed, to probe 
whether the expression of key placental ABC transporters is associated with the pathological and clinical features 
of human malaria during pregnancy20.
Results
pregnancy-associated malaria induces preterm delivery and intra uterine growth restriction. 
Pilot studies were conducted to determine the appropriate infected-erythrocyte regimen necessary for eliciting 
PTD in 10–20% of the animals, on GD17.5. This stage of gestation was selected based on evidence that murine 
term birth occurs between GD18 and 22, with an average gestational period of 19.25 days for C57BL/6 mice21. 
Importantly, C57BL/6 birth occurs at GD18.5 in our animal facilities, which is compatible with the average 
birth age observed for term deliveries in the C57BL/6 lineage elsewhere21. In addition, C57BL/6 concepti on 
GD17.5, exhibit fetal development markers consistent with infants born prematurely22. Thus we considered that 
all C57BL/6 births occurring in our facilities prior to 18.5 were to be classified as PTD.
Pregnant mice were acutely exposed to 1 × 105, 5 × 105 or 1 × 106 infected-erythrocytes (n = 2/group) 
on GD13.5, and the percentage of vaginally born dead  fetuses was recorded. Mice exposed to 1 × 105 
infected-erythrocytes did not exhibit any signs of being born vaginally prior to GD18.5. On the other hand, the 
percentage of vaginally-born dead fetuses, among mice that received 5 × 105 infected erythrocytes, was 12.5%, 
and, among the animals which received 1 × 106 infected erythrocytes, this percentage was 100% (Supplementary 
Table 1). This pilot experiment was primarily conducted to obtain an effective dose and a point at which to 
start the establishment of a malaria induced-preterm labor model. Thus, we expanded this preliminary finding 
and administered 5 × 105 infected erythrocytes (n = 20) or phosphate buffered saline (PBS - control; n = 12) on 
GD13.5, for posterior morphological analyses and protein/gene expression studies.
As shown in Table 1, pregnant malaria-infected mice (5 × 105 infected erythrocytes) displayed reduced 
body weight gain between GD 13.5 and 18.5, and increased spleen weight, when compared to the control group 
(P = 0.011 and P < 0.001, respectively). However, there were no observable differences in litter size or fetal death 
rate between the two groups. Additionally, the results indicated that our model of gestational malaria promoted 
PTD, since 4 out of 20 females (20%) infected with Plasmodium berghei ANKA went into PTD on GD 17.5. i.e., 
exhibited visual signs of vaginal delivery on GD17.5. It was not possible to collect the placentae and fetuses 

















Control 12 6.5 ± 0.3 79.8 ± 3.4 5.4 ± 0.8 0 (0/80) 0 (0/12) 82.2 ± 0.8 1123 ± 47.5 13.6 ± 0.6
Malaria 20 3.78 ± 0.8* 153.8 ± 10.4**** 5.7 ± 1.2 1 (1/99) 20 (4/20) 83.4 ± 0.1 843.9 ± 55.85** 9.71 ± 0.84**
Table 1. Summary of pregnancy characteristics in Plasmodium berghei Anka infected mice and control mice at 
GD18.5. Values are expressed as the mean ± SEM. *P < 0.05, **P < 0.01 and ****P < 0.0001.
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on the day of euthanasia, GD 18.5, a gestational period when fetal growth, placental volume and maternal and 
fetal blood vessel surface areas peaks23. Offspring from malaria-infected mothers displayed reduced birth weight 
(P = 0.001) and fetal:placental (F:P) weight ratios (P = 0.002), with no significant changes in placental weight 
(Table 1). The average of peripheral parasitemia in the Plasmodium-infected group obtained on day GD18.5, 
immediately before euthanasia, was 16% of infected erythrocytes.
Pregnancy-associated malaria causes an intense systemic inflammatory response. Serum lev-
els of IL1-β, IL-6, CXCL1 and MCP-1 were evaluated to determine whether gestational malaria induced a systemic 
inflammatory response. As shown in Fig. 1, there was an associated increase in IL1-β (Fig. 1B, P = 0.03), IL-6 
(Fig. 1C, P = 0.001), CXCL1 (Fig. 1D, P = 0.001) and MCP-1 (Fig. 1E, P = 0.003) serum levels in malaria-infected 
mice, when compared to the control group, on GD18.5.
Pregnancy-associated malaria induces specific placental ultrastructural alterations. Since 
gestational malaria, induced by Plasmodium berguei ANKA infection, reduced the F:P ratio, we analyzed the 
relative proportions of labyrinth and spongiotrophoblast areas, using PAS staining. There were no alterations in 
total placental, labyrinth and spongiotrophoblast areas, indicating the absence of gross morphological change 
(Fig. 2A). Evidence of placental accumulation of Plasmodium-infected erythrocytes was assessed using TEM 
(Fig. 2B), and revealed that infected erythrocytes were present in the labyrinthine sinusoids and were adhering to 
the labyrinthine interhemal membrane exchange site, which is consistent with previous work24. Ultrastructural 
analyses, using TEM, indicated that the labyrinth area (Fig. 2C) of control placentae was enriched with euchro-
matic nuclei and to a lesser extent, heterochromatin regions. Additionally, microvilli in sinusoidal trophoblastic 
giant cells and large agranular endoplasmic reticulum were observed. Conversely, malaria-infected placentae 
(Fig. 2D), despite exhibiting large agranular endoplasmic reticulum, lacked or displayed fewer microvilli in 
Figure 1. Plasmodium berghei Anka infection during pregnancy elicited an intense maternal inflammatory 
response. (A) Chart of the experimental design. Measurement of specific cytokine and chemokine contents 
in the maternal serum from pregnant mice infected with Plasmodium berghei ANKA on GD18.5. (B) IL1-β 
(n = 10/8); (C) IL-6 (n = 9/10); (D) CXCL1 (n = 10/10); (E) MCP-1 (n = 10/10). Values are expressed as the 
mean ± standard error. The unpaired Student’s t test was employed the for IL1-β, IL-6 and MCP-1 comparisons, 
and the Mann-Whitney test was used for comparing CXCL1 values.
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the sinusoidal trophoblastic giant cells. Furthermore, the spongiotrophoblasts from control placentae (Fig. 2E) 
exhibited euchromatic nuclei, evident nucleoli, substantial mitochondrial content and large agranular endoplas-
mic reticulum. In contrast, malaria-infected placentae (Fig. 2F) contained a greater number of heterochromatic 
regions and contained granular endoplasmic reticulum with dilated cisterns.
Placental malaria increases cell proliferation without altering the apoptotic index. Since we did 
not observe changes in placental weight following Plasmodium berghei ANKA infection, we investigated whether 
proliferation or apoptotic rates were altered in gestational malaria. Using the Ki-67 proliferation marker25, 
Figure 2. Evidence of Plasmodium berghei ANKA-infected erythrocyte accumulation and associated 
ultrastructural alterations in the placental labyrinth and spongiotrophoblast zones. (A) Placental gross 
morphological analysis. Periodic acid-Schiff staining of control and malaria-infected mice, evaluating total 
placental, labyrinth (L) and spongiotrophoblast (S) areas. (B) Transmission electron photomicrograph of 
malaria-infected erythrocyte adhering to labyrinthine trophoblast giant cell (TGC). (C,D) Transmission 
electron photomicrographs of the placental labyrinth. (D,E) and spongiotrophoblast areas. AER = *agranular 
endoplasmic reticulum; Δ dilated granular endoplasmic reticulum; Mt = mitochondria; Mv = microvilli; 
EN = euchromatic nucleus; PBA = Plasmodium berghei ANKA; RBC = red blood cell; SS = sinusoidal space; 
TGC = trophoblast giant cell; White arrows HA = heterochromatin area; White arrow heads = nucleolus. Scale 
bar = 2 µm (2B); 5 µm (2C-F).
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immunohistochemistry analysis revealed an increase in total placental cell proliferation (Fig. 3C, P = 0.001), 
which was more evident in the labyrinth (Fig. 3C, P = 0.050) than the spongiotrophoblast zone of the murine 
placenta. Conversely, TUNEL analysis did not reveal any significant differences in the apoptotic index in the total 
placental area or in the labyrinth/spongiotrophoblast zones (Fig. 3D–F).
Figure 3. Placental malaria induces hyperproliferation in the labyrinth zone. (A) Representative 
immunohistochemistry images of Ki-67 positive cell nuclei in control and (B) pregnant malaria infected mice. 
(C) Graphs represent Ki-67 counting in the total placental, spongiotrophoblast and labyrinth area, respectively. 
(D) Immunohistochemical staining for apoptotic nuclei detection, using the TUNEL method, in the placenta of 
control and (E) malaria-infected mice. (F) Graphs show the apoptotic cell nuclei counting in the total placental, 
spongiotrophoblast and labyrinth areas, respectively. Black arrows = Ki-67/TUNEL stained nuclei. Values are 
expressed as the mean ± SEM. The labyrinth, spongiotrophoblast and total placental area values, in both Ki-67 
and TUNEL experiments were analyzed using the unpaired Students T-test. N = 5/group. Scale bar = 50 μm.
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Pregnancy-associated malaria induces placental and maternal hepatic inflammatory responses 
and impairs ABC transporter gene expression. The expression of Abca1, Abcb1b, Abcb9 and Abcg2 
was downregulated in the placentae of Plasmodium berghei ANKA-infected mice (Fig. 4A, P < 0.05), whereas 
there was a 2-fold increase in Cxcl1 and a 1.4-fold increase in Ccl2 mRNA expression, when compared to con-
trols (Fig. 4A, P < 0.05). In order to determine if the effects of PAM on ABC transporters regulation were tissue 
specific, the expression of key ABC transporters was also assessed in the maternal liver. Hepatic levels of Abcb1a, 
Abcb9, Abcc2 and Abcg2 mRNA were reduced (Fig. 4B, P < 0.05), however, the expression of Abca1 and Abcb1b 
were not affected by PAM. In addition, Il1b expression in the liver was upregulated in the malaria-infected group, 
when compared to controls (Fig. 4B, P < 0.05).
Pregnancy-associated malaria impairs protein expression of major ABC transporters involved 
in cholesterol transfer and fetal protection. Due to the fact that Abca1, Abcb1b and Abcg2 were down-
regulated in malaria infected pregnancies, the protein expression levels of the correspondent best described ABC 
transporters, ABCA1, P-gp and BCRP were assessed. Consistent with the gene expression responses, the levels of 
ABCA1, P-gp and BCRP protein were significantly reduced in the malaria infected animals, when compared to 
controls (Fig. 5A–C).
Discussion
In this study, we have developed a new murine model of MiP that recapitulates many of the features associated 
with human placental malaria26. For example, the accumulation of Plasmodium-infected erythrocytes into the 
labyrinthine sinusoids, IUGR and PTD were all observed in this animal model. There were also intense maternal 
systemic and placental inflammatory responses. Placental ultrastructural analyses of labyrinthine cells revealed a 
loss of microvilli in sinusoidal trophoblastic giant cells, whereas spongiotrophoblasts exhibited a greater number 
Figure 4. Pregnancy associated malaria induces an inflammatory response in the placenta and maternal 
liver and downregulates the expression of key ABC transporter genes. (A) Placental levels of Abca1, Abcb1a, 
Abcb1b, Abcb4, Abcb9, Abcc2, Abcc5, Abcg1, Abcg2, Abcf2, Il6, Cxcl1, Ccl2 and Il1b mRNA (n = 12/16). (B) 
Levels of Abca1, Abcb1a, Abcb1b, Abcb9, Abcc2, Abcg2 and Il1b mRNA in the maternal liver (n = 12/14). The 
broken line indicates the expression levels in the control group which were set to one. Values are expressed as 
the mean ± SEM. *P < 0.05. Unpaired Students t-tests were undertaken in both the placenta and maternal liver 
analysis.
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of heterochromatic regions and granular endoplasmic reticulum with dilated cisterns. Infected mice exhibited 
reduced placental levels of Abca1, Abcb1b, Abcg2 and Abcb9 mRNA, which were accompanied by reductions in 
placental ABCA1, BCRP and P-gp protein.
Using C57BL/6 mice infected with P. berghei ANKA, we were able to induce placental malaria, IUGR and 
PTD. Typically, this type of infection is used to induce cerebral malaria, which is a more severe form of the dis-
ease19,27. Furthermore, C57BL/6 mice are particularly more susceptible to P. berghei ANKA infection compared 
to the BALB/c mice19. This likely account for the more severe phenotype observed in pregnant C57BL/6 mice, 
compared to pregnant BALB/c mice infected with P. berghei ANKA12,20. However, it is important to note that 
pregnant BALB/c mice infected with P. berghei ANKA also exhibit IUGR, syncytiotrophoblast damage, placental 
parasite accumulation and inflammation, as well as, increased maternal spleen weight and decreased maternal 
weight28,29. In this context, the average parasitemia observed on GD18.5 in C57BL/6 Plasmodium-infected mice 
(16% of infected erythrocytes) is consistent with the average observed in Plasmodium-infected BALB/c mice20, 
suggesting that this range of parasitemia is consistently, associated with trophoblast disruption in different exper-
imental murine malaria models.
The dose of P. berghei ANKA (5 × 105) used following pilot studies, induced PTD in 20% of the mice, pro-
moted IUGR and reduced the F:P weight ratio. The latter is an indirect measure of placental efficiency30, indicat-
ing that placentae from malaria-infected mice are less efficient, and likely accounting for the reduced fetal weight 
observed. Use of TEM, allowed us to detect less sinusoidal trophoblastic giant cells -microvilli in the labyrinth 
of malaria-infected placentae, indicating impaired placental uptake of nutrients from the maternal blood and 
possibly explaining, at least in part, the decreased placental efficiency. In parallel, malaria infection compromised 
maternal weight gain, which might well contribute to the observed IUGR phenotype in this model.
Figure 5. Placental malaria decreases ABCA1, P-glycoprotein and breast cancer resistance protein expression 
in the placenta. Representative immunohistochemistry images and immunostaining quantification of (A) 
ABCA1; (B) P-gp; and (C) BCRP in the placenta of control and malaria-infected mice. The black arrows 
represent ABCA1/P-gp/BCRP stained cells. Graphs represents the % of stained cells/viable tissue. Values are 
expressed as the mean ± SEM. The unpaired Student’s t test was used. N = 5. *P < 0.05, **P < 0.004. Scale 
bar = 50 μm.
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One of the hallmarks of human placental pathogenesis in malaria is the accumulation of Plasmodium-infected 
erythrocytes into the intervillous space of the placenta, which adhere to specific glycosaminoglycans expressed in 
the syncytiotrophoblasts31,32. Here, we provide evidence that P. berghei ANKA infected erythrocytes were accu-
mulated into the labyrinthine sinusoid space of infected mice, which is bathed in maternal blood. Accumulation 
of infected-erythrocytes was also described in a BALB/c model of MiP20, thus demonstrating that this pathogen 
has the ability to induce placental malaria in different mouse strains. In addition, other ultrastructural changes 
were detected in the spongiotrophoblast zone of infected animals. These include the presence of well-developed 
granular endoplasmic reticulum with dilated cisterns. These findings are indicative of increased protein accu-
mulation in the placenta, and could be related to the increase in labyrinthine cell proliferation. It is also possible 
that hyperproliferation of the labyrinth zone is a placental adaptation necessary for meeting the fetal growth 
requirements in this severe pathological state, without altering placental weight, the apoptotic ratio or gross mor-
phology. Alternatively, it may be a direct response to placental inflammation, triggered by the presence of infected 
erythrocytes in the sinusoidal space of the placenta.
The upregulation in placental Cxcl1 mRNA expression, a human IL-8 analog, is another important finding, 
and may play a role in the increased PTD rate, since this cytokine has been directly linked to the inflammatory 
milieu typically found in pregnancies with a heightened risk for PTD33. Furthermore, the increase in Il1-b mRNA 
expression in the maternal liver, not only serves as an indicator of systemic inflammation, but may also be linked 
to the downregulation of specific ABC transporter expression in the placenta and maternal liver34. Furthermore, 
increased maternal plasma cytokine levels, especially IL1-β and IL-6, are established markers of the inflammatory 
response responsible for cervical ripening and PTD induction35.
Following the development of a MiP model that recapitulates many of the features of the disease in humans, 
we set out to investigate the placental expression of selected ABC transporters, which are related to nutrient trans-
fer and fetal protection against drugs and environmental toxins. Among these transporters, it was found, for the 
first time, that both the gene and protein expression levels of Abca1 were downregulated in placental malaria. In 
humans, this protein is predominantly expressed in the apical membrane of syncytiotrophoblasts, and functions 
to transport cholesterol, phospholipids and cytotoxic oxysterols out of the cell and into the maternal circula-
tion36. Importantly, ABCA1 also extrudes inflammatory mediators, such as the macrophage migration inhibi-
tory factor (MIF) which are associated with inflammatory processes involved in the onset of PTD37. Impaired 
placental expression of Abca1, in placental malaria, may result in compromised lipid homeostasis, as evidenced 
by the presence of well-developed agranular endoplasmic reticulum with dilated cisterns in labyrinthine cells. It 
may also result in accumulation of cytotoxic oxysterols and/or MIF in the fetal compartment. Placental Abcb9 
mRNA expression was also downregulated in malaria-infected mice; however, whether this decrease is related to 
malarial infection that leads to PTD, remains to be determined; its location in the placental barrier is unknown. 
Notwithstanding, this protein has been shown to be involved in inflammatory responses associated with T lym-
phocytes38 and expression of its mRNA is disrupted in human preterm placentas with chorioamnionitis18.
Placental malaria decreased Abcb1b and Abcg2 mRNA and their protein products P-gp and BCRP. These pro-
teins represent major multidrug resistance transporters, and a reduction in placental expression is consistent with 
previous findings demonstrating that bacterial and viral challenges can decrease human placental P-gp and BCRP 
expression and murine placental P-gp activity15–18. These findings are also consistent with a previous study from 
Cressman et al., who demonstrated that Plasmodium berghei ANKA-infected BALB/c mice exhibited reduced pla-
cental Abcb1b and Abcg2 mRNA expression and decreased P-gp protein expression. On the other hand, contrary 
to our findings, Cressman et al. also demonstrated a reduction in the placental expressions of Abcb1a and Abcc2 
and an increase in the hepatic expression of Abcb1b, which can be explained by the use of different mouse strains 
and experimental designs12. However, it remained to be determined whether placental reduction of these multi-
drug resistance transporters was associated with the pathogenesis of malarial-induced PTD and related IUGR. 
In this connection, here we show for the first time a reduction in placental P-gp and BCRP expression could be 
potentially involved in the mechanisms of malarial induced PTD and IUGR. Importantly, P-gp and BCRP have 
been related to the pathogenesis of PTD induced by chorioamnionitis18, whereas impaired P-gp expression has 
been demonstrated in placentas from growth restricted preterm fetuses39. Moreover, P-gp and BCRP are enriched 
in the apical membrane of syncytiotrophoblasts and transport their substrates from fetal to maternal circulation. 
Impaired placental expression of these multidrug resistance transporters during MiP, could potentially augment 
the fetal accumulation of drugs commonly prescribed during pregnancy, including: antibiotics, antihistamines, 
antiretrovirals, NSAIDs and others13, as well as increase fetal exposure to different environmental toxicants. Such 
an accumulation could negatively impact fetal outcome, gestational length or influence the dose requirements of 
these medications in pregnant malaria-infected individuals. These possibilities, however, require further inves-
tigation given that reduction in ABCA1, P-gp and BCRP expression, while significant, were of only moderate 
magnitude.
In the maternal liver, there was a decrease in Abcb1a, Abcc2, Abcb9 and Abcg2 gene expression, whereas in 
the placenta, we observed a decrease in Abca1, Abcb1b, Abcb9 and Abcg2. With the exception of Abcb1b, a sim-
ilar pattern was also observed in Plasmodium berghei ANKA-infected BALB/c mice12, which may indicate that 
gestational malaria elicits similar regulatory pathways for the expression of ABC transporters in different tissues. 
Importantly, expression of Abcc2, a transporter related to bile salt excretion in the liver, was assessed as dysregu-
lation of bile salts in the maternal serum has been linked to PTD12.
Limitations of the present model include our inability to dissociate effects from experimental cerebral malaria 
(ECM) and effects associated with the onset of PTD. However, it is important to note that mice were closely 
monitored daily between GD 13.5 and GD 18.5 and behavior associated with ECM including ataxia and paralysis 
was evident from GD17.5. Suggesting that consequences of ECM may be associated with the phenotype herein 
observed.
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In conclusion, the present study describes a new model of pregnancy-associated malaria using C57BL/6 mice 
infected with Plasmodium berghei ANKA. This model recapitulates features commonly observed in human MiP, 
including IUGR and PTD. Based on the results, IUGR may result from the loss of labyrinthine-microvilli, as well 
as the downregulation of selected ABC transporters and other placental nutrient and drug transporters previously 
demonstrated to be altered in human and experimental MiP. However, this is the first time that dysregulation of 
placental ABC transporters has been related to malaria induced-preterm labor. These alterations are probably due 
to the sequestration of malaria-infected erythrocytes into the placental sinusoidal space, leading to an intense 
pro-inflammatory response, potentially resulting in increased levels of harmful physiological and pharmacolog-
ical factors in the placenta and fetal circulation.
Materials and Methods
Animal experimentation and Study Design. Mice used in this study were housed in a temperature-con-
trolled room (23 °C), under a 12/12 h light/dark cycle, and had free access to fresh food and water. In total, 32 
virgin female C57BL/6 mice (8–10 weeks of age) were bred with 10 C57BL/6 males, as previously described15. The 
following morning, the female mice were examined for vaginal plugs. If present, female mice were considered to 
be at gestational day 0.5 (GD0.5). This study was approved by the Animal Care Committee of the Health Sciences 
Center, Federal University of Rio de Janeiro (CEUA-190/13) and registered with the Brazilian National Council 
for Animal Experimentation Control. The animal’s human humane cares were in compliance with the “Principles 
of Laboratory Animal Care” formulated by the National Society for Medical Research and the U.S. National 
Academy of Sciences Guide for the Care and Use of Laboratory Animals.
On GD13.5, shortly after the complete formation of murine placental circulation40, animals were injected 
intraperitoneally (i.p). with a single dose of Plasmodium berghei ANKA-infected erythrocytes (5 × 105 
infected-erythrocytes, n = 20) or phosphate buffered saline (PBS - control; n = 12), as described previously20,41, 
with modifications. The murine Plasmodium berghei ANKA model of malaria infection was chosen because it 
recapitulates many features of pregnancy-associated malaria20. In the present study, we have adapted its use to 
generate a new murine model of malaria-induced PTD, associated with IUGR. Briefly, murine infection was 
achieved with infected erythrocytes, obtained from animals exposed to cryopreserved protozoa. Pilot stud-
ies were conducted to determine the appropriate infected-erythrocyte regimen necessary for eliciting PTD in 
10–20% of the animals, on GD17.5. This stage of gestation was selected based on evidence that murine term birth 
occurs between GD18 and 22, with an average gestational period of 19.25 days for C57BL/6 mice21.
On GD18.5, maternal parasitemia was determined using Giemsa-stained thick blood smears obtained from 
caudal vein, before euthanasia. The percentage of infected erythrocytes was defined as the number of erythrocytes 
infected per 100 erythrocytes counted in ten fields, using light microscopy.
On the morning of GD18.5, both groups were anesthetized with isoflurane (Cristalia, São Paulo, Brazil), and 
euthanized by decapitation. Maternal plasma was harvested by cardiac puncture, placed into heparinized tubes 
on ice, immediately centrifuged (1,077 × g, 15 min) and frozen at −80 °C until the analysis of cytokine lev-
els. The maternal liver was dissected and preserved in RNAlater stabilizing solution (Thermo Fisher Scientific, 
Massachusetts, USA), and stored at −70 °C until qPCR analysis. The weight of the maternal spleen was also 
recorded.
Following decapitation, the fetuses and placental discs were dissected and weigthed. Two placentae, with 
wet weights closest to the mean weight of all placentae, were selected from each litter42 for qPCR analysis, or 
incubated in 4% buffered paraformaldehyde (Sigma-Aldrich, Missouri, USA) for morphological evaluation and 
assessment of protein levels and localization.
qPCR. Total RNA from the maternal liver and placental discs was extracted using the TRIzol method accord-
ing to the manufacturer’s instructions (TRIzol Reagent; Life Technologies, California, USA). RNA concentra-
tion and purity were assessed spectrophotometrically by measuring the absorbance values at 260 nm and the 
A260/A280 respectively, whereas RNA integrity was confirmed by gel electrophoresis. Total RNA (1 μg) was 
used to synthesize cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, São 
Paulo, Brazil) according to the manufacturer’s instructions. The mRNA levels of selected ABC transporters and 
pro-inflammatory cytokines and chemokines (Table 2) were measured by qPCR using the Maxima SYBR Green/
ROX qPCR Master Mix 2 × (Thermo Fisher Scientific, Massachusetts, USA) and Master Cycler Realplex system 
(Eppendorf, Germany), with the following cycling conditions: combined initial denaturation at 50 °C (2 min) and 
95 °C (10 min), followed by 40 cycles of denaturation at 95 °C (15 s), annealing at 60 °C (30 s) and extension at 
72 °C (45 s). Gene expression was normalized to the geometric mean of reference genes, Gapdh and Ywhaz, which 
exhibited stable expression levels following Plasmodium berghei ANKA infection (Table 2). Relative gene expres-
sion was calculated according to the 2−ΔΔCT method43. The assay was considered acceptable when its efficiency 
ranged from 95 to 105%. DNA contamination was ruled out using intron-spanning primers (Table 2), reverse 
transcriptase-negative samples and melting curve analyses obtained from each qPCR reaction. All samples and 
standards were measured in duplicate.
Histological analysis of the placenta, immunohistochemistry and tUneL. Fixed placentae were 
dehydrated protocol with increasing concentrations of ethanol, diaphanization in xylol and inclusion in paraffin. 
The blocks were sectioned (5 μm), using a Rotatory Microtome CUT 5062 (Slee Medical GmbH, Germany), 
and sections subjected to Periodic Acid-Schiff (PAS) staining and immunohistochemistry. Following diapha-
nization with three xylene immersions, and hydration with decreasing concentrations of ethyl alcohol (100%, 
90% and 70%), placental sections were oxidized with 0.5% periodic acid (Sigma-Aldrich, Missouri, USA) for 
15 minutes, washed in distilled water and incubated with Schiff ’s reagent (Merck, Germany; 10 min, room tem-
perature). Subsequently, each section was washed with distilled water, stained with hematoxylin (Proquímios, 
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Rio de Janeiro, Brazil), dehydrated with increasing concentrations of ethyl alcohol (70%, 90%, 100%), clarified in 
xylene and mounted with Entellan (Merck, Germany). The limit between the maternal and fetal components of 
the placenta was identified by the presence of giant trophoblastic cells (GTC), which separate the basal decidua 
from the junctional zone40, and the area of each region was measured using the free-drawing tool of the Image J 
software (National Institutes of Health, Maryland, USA).
For immunohistochemical analyses, following deparaffinization and rehydration, sections were exposed to 
hydrogen peroxide (3%) diluted in PBS. Excess peroxide was removed with PBS + Tween. Antigen retrieval was 
achieved by immersing the slides in Tris-EDTA buffer (pH 9.0), followed by immersion in sodium citrate buffer 
(pH 6.0), in the microwave (15 minutes for Tris-EDTA buffer and 8 minutes for citrate buffer). The slides were 
then incubated in bovine serum albumin (3%) in PBS, for 1 hour to block non-specific antibody binding. Slides 
were then incubated with primary antibodies for: Ki67 (1:100; Spring Bioscience, California, USA), P-gp (1:500; 
Santa Cruz Biotechnology, Texas, USA), BCRP (1:100; Merck Millipore, Massachusetts, USA) or ABCA1 (1:100; 
Abcam Plc, UK) overnight at 4 °C. The next day, the slides were incubated with biotin-conjugated secondary 
antibody (SPD-060 - Spring Bioscience, California, USA) for 1 hour. After incubation with streptavidin (SPD-
060 - Spring Bioscience, California, USA) for 1 hour, the reaction was stopped with 3,3-diamino-benzidine (DAB) 
(SPD-060 - Spring Bioscience, California, USA). The terminal deoxynucleotidyl transferase dUTP nick end labe-
ling (TUNEL) method was used for the detection of apoptotic nuclei, using the ApopTag® In Situ Peroxidase 
Detection Kit (Merck Millipore, Massachusetts, USA), according to the manufacturer’s recommendations.
After immunostaining and TUNEL, the sections were counterstained with hematoxylin, dehydrated in 
increasing concentrations of ethanol and immersed in xylol and mounted with laminula and Entellan (Merck, 
Germany). Sections were imaged, under bright-field illumination, with a high-resolution Olympus DP72 camera 
(Olympus Corporation, Japan) coupled to an Olympus BX53 light microscope (Olympus Corporation, Japan).
Quantification of Ki-67 and TUNEL immunostained nuclei was performed using the STEPanizer software44. 
Fifteen digital images were captured per tissue fragment of each placental zone (labyrinth and spongiotroph-
oblast) in 5 control mice and 5 malaria-infected mice, totaling 300 digital images analyzed: five animals with 
parasitemia value closest to the global parasitemia average in the MiP group, whereas control animals were 
randomly selected. The Ki-67 and TUNEL immunostained nuclei from each image were divided by the image 
area, which yielded an estimate for the number of proliferative or apoptotic nuclei present in the whole tissue45. 




Abca1 5′GCAGATCAAGCATCCCAACT 3′3′CCAGAGAATGTTTCATTGTCCA 5′
48 NM_013454.3
Abcb1a 5′GGGCATTTACTTCAAACTTGT 3′3′TTTACAAGCTTCATTTCTCAA 5′
48 NM_011076.3
Abcb1b 5′AAGCCAGTATTCTGCCAAGCAT 3′3′CTCCAGACTGCTGTTGCTGATG 5′
48 NM_011075.2
Abcb4 5′GAAGGGATCTACTTCAGACTCGTT 3′3′TCAACTTCAAATTCTTCTGACAGG 5′
48 NM_008830.2
Abcb9 5′GTGTATTGTTGGATGGCAAGC 3′3′GGAGATGTTGTCTGTGATGGAG 5′
49 NM_019875.2
Abcc2 5′TAATGAGGCGCCGTGGGTGAC 3′3′GTCCTGCCCACCACACCGAC 5′
50 NM_013806.2
Abcc5 5′AAATGTATGCCTGGGTCAAAGC3′3′TGGCGATCACTACCACAATAGG5′ * NM_013790.2
Abcg2 5′TGCCAGGCGCTCATTTAAAAACTTGC3′3′GCATTCCAGCGGCATCATATTTCAGA 5′
50 NM_011920.3
Abcf2 5′TGTCCACATTATCAACCTCTCCC 3′3′TCACGTTTCCCAATAGCCGAG 5′ * NM_013853.2
Il6 5′GAGGATACCACTCCCAACAGACC 3′3′AAGTGCATCATCGTTGTTCATACA 5′
49 NM_031168.2
Cxcl1 5′ACCCGCTCGCTTCTCTGT 3′3′AAGGGAGCTTCAGGGTCAAG 5′
49 NM_008176.3
Ccl2 5′GGTCCCTGTCATGCTTCTGG 3′3′CCTGCTGCTGGTGATCCTCT 5′
51 NM_011333.3
Gapdh 5′TGTGTCCGTCGTGGATCTGA 3′3′TTGCTGTTGAAGTCGCAGGAG 5′
52 NM_001289726.1
Ywhaz 5′ GAAAAGTTCTTGATCCCCAATGC 3′5′ TGTGACTGGTCCACAATTCCTT 3′ * NM_011740.3
β-actin 5′ AAATCTGGCACCACACCTTC 3′5′ GGGGTGTTGAAGGTCTCAAA 3′
53 NM_007393.5
Ppib 5′ GAGACTTCACCAGGGG 3′5′ CTGTCTGTCTTGGTGCTCTCC 3′ * NM_011149.2
Rplp0 5′ GGCCCTGCACTCTCGCTTTC 3′5′ TGCCAGGACGCGCTTGT 3′ * NM_007475.5
Table 2. Primers Used in The Present Study. *Gene specific primers were designed with primer-BLAST (http://
www.ncbi.nlm.gov/tools/primer-blast).
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software (Media Cybernetics, Maryland, USA), where only the percentage of viable tissue area was considered, 
and empty spaces of the images were excluded. A total of 30 digital images per placenta (15 digital images for each 
placental area, labyrinth and spongiotrophoblast) were evaluated in each experimental group.
transmission electron microscopy (teM). After euthanasia, placental fragments were fixed in glutaral-
dehyde (Sigma-Aldrich, Missouri, USA, 2.5%, 48 hours). The fragments were then immersed in cacodylate buffer 
(Sigma-Aldrich, Missouri, USA; 3 × 15 minutes). Samples were post-fixed (60 minutes) with osmium tetroxide 
and potassium ferrocyanide. The placental fragments were dehydrated in increasing concentrations of PA ace-
tone (30%, 50%, 70%, 90% and 2 × 100%) and subjected to EPOXI resin infiltration using baths with increasing 
ratios of EPOXI resin to PA acetone (1:2, 1:1 and 2:1). After polymerization, semi-thin sections (2 µm) (Leica 
Microsystems, Germany) were produced. To select the region to be analyzed, ultra-thin sections (70 nm) (Leica 
Microsystems, Germany) were used, which were further contrasted with uranyl acetate and lead citrate and later 
visualized using a JEM-1011 transmission electron microscope (JEOL Ltd., Japan).
Measurement of Serum Cytokine and Chemokine levels. Maternal serum interleukin (IL)-6, IL1-β, 
monocyte chemoattractant protein-1 (MCP-1/CCL2) and the chemokine (C-X-C motif) ligand 1 (CXCL1) con-
centrations were measured using the commercially available MILLIPLEX-MAP Mouse Cytokine/Chemokine 
Magnetic Bead Panel – Immunology Multiplex Assays (Merck Millipore, Massachusetts, USA), according to 
manufacturer’s protocol recommendations, and fluorescence intensity was detected using a Luminex 200™ sys-
tem (Merck Millipore, Massachusetts, USA).
Statistical analysis. All data are expressed as the mean ± standard error of the mean (SEM). Normality tests 
were applied to evaluate normal distribution. The Student’s T-test or non-parametric Mann-Whitney test were 
applied accordingly when performing comparisons between the two groups. Statistical assessment of pregnancy 
parameters, were undertaken using the mean value of all fetuses in a litter for each C57BL/6 mother, and not the 
individual fetuses. For qPCR and immunostaining data, closest placentae to the mean weight of all placentae 
were selected from each litter. Thus “n” represents the number of litters42,46,47. Statistical analyses were performed 
using the Graphpad prism 6 software (GraphPad, Inc., California, USA) and differences were considered to be 
significant at P < 0.05.
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